Gaslightwala Abizer, CEO of Akari Therapeutics Plc ($AKTX), made seven open market purchases of company shares over the past year, totaling nearly $57,000. His most recent buy occurred on August 25, 2025. Among nearly 5,000 insiders tracked for open market buys, his activity ranks in 2,863rd place by purchase value, compared to an average of about $1.5 million per insider and 3.3 transactions. Abizer reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | P | Pre-Funded Warrants to purchase ADRs | 309328 | $0.40 | 309,328.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | P | Pre-Funded Warrants to purchase ADRs | 773323 | $0.40 | 773,323.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | P | Warrants to purchase ADRs | 773323 | $0.00 | 773,323.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Dec. 16, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | P | Warrants to purchase American Depositary Shares ("ADRs") | 309328 | $0.00 | 309,328.0000 | 71,479,461,523 | 9999.99% | 0.00% |
| Aug. 21, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | P | American Depositary Shares representing Ordinary Shares | 10000 | $0.94 | 287,574.0000 | 57,752,981,523 | 3.60% | 0.00% |
| Aug. 25, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | P | American Depositary Shares representing Ordinary Shares | 3000 | $0.90 | 298,574.0000 | 57,752,981,523 | 1.01% | 0.00% |
| Aug. 22, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | P | American Depositary Shares representing Ordinary Shares | 8000 | $0.93 | 295,574.0000 | 57,752,981,523 | 2.78% | 0.00% |
| June 23, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | President & CEO | P | American Depositary Shares representing Ordinary Shares | 943 | $1.15 | 272,371.0000 | 57,752,981,523 | 0.35% | 0.00% |
| June 24, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | President & CEO | P | American Depositary Shares representing Ordinary Shares | 5203 | $1.16 | 277,574.0000 | 57,752,981,523 | 1.91% | 0.00% |
| June 20, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | President & CEO | P | American Depositary Shares representing Ordinary Shares | 10000 | $1.20 | 271,428.0000 | 57,752,981,523 | 3.83% | 0.00% |
| June 17, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | President & CEO | P | American Depositary Shares representing Ordinary Shares | 15000 | $1.20 | 261,428.0000 | 57,752,981,523 | 6.09% | 0.00% |
| June 13, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | A | American Depositary Shares representing Ordinary Shares | 25000 | $1.19 | 246,428.0000 | 57,752,981,523 | 11.29% | 0.00% |
| June 12, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | A | American Depositary Shares representing Ordinary Shares | 20000 | $1.23 | 221,428.0000 | 57,752,981,523 | 9.93% | 0.00% |
| June 10, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | CEO | A | American Depositary Shares representing Ordinary Shares | 20000 | $1.27 | 201,428.0000 | 57,752,981,523 | 11.02% | 0.00% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | Stock Option (Right to Buy) | 1100000 | $0.00 | 1,100,000.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | Series B Warrants (Right to Buy) | 133928 | $1.12 | 133,928.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | Series A Warrants (Right to Buy) | 133928 | $1.12 | 133,928.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | American Depositary Shares representing Ordinary Shares | 133928 | $1.12 | 181,428.0000 | 0 | 281.95% | 0.00% |
| Jan. 10, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | American Depository Shares representing Ordinary Shares | 11640 | $1.22 | 47,500.0000 | 0 | 32.46% | 0.00% |
| Jan. 10, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | American Depository Shares representing Ordinary Shares | 11439 | $1.22 | 35,860.0000 | 0 | 46.84% | 0.00% |
| Jan. 3, 2025 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | Ordinary Shares, par value $0.0001 per share | 1720000 | $0.00 | 71,720,000.0000 | 0 | 2.46% | 0.00% |
| Dec. 27, 2024 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | Ordinary Shares, par value $0.0001 per share | 40000000 | $0.00 | 70,000,000.0000 | 0 | 133.33% | 0.00% |
| Dec. 26, 2024 | Akari Therapeutics Plc | $AKTX | Gaslightwala Abizer | Not found | A | Ordinary Shares, par value $0.0001 per share | 30000000 | $0.00 | 30,000,000.0000 | 0 | 9999.99% | 0.00% |